Nurexone Biologic Inc
(NRX.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,588 | 2,463 | 3,151 | 4,018 | 1,562 |
| Receivables | 259 | 52 | 197 | 373 | 186 |
| Other current assets | 54 | 54 | 54 | 17 | 19 |
| TOTAL | $1,901 | $2,692 | $3,402 | $4,408 | $1,767 |
| Non-Current Assets | |||||
| PPE Net | 143 | 102 | 114 | 111 | N/A |
| TOTAL | $143 | $102 | $114 | $111 | $0 |
| Total Assets | $2,044 | $2,794 | $3,516 | $4,519 | $1,767 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,081 |
| Accrued Expenses | 301 | 456 | 142 | 167 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 130 |
| TOTAL | $569 | $583 | $699 | $660 | $1,578 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 68 | 95 | 85 | 72 | 63 |
| TOTAL | $81 | $115 | $110 | $109 | $63 |
| Total Liabilities | $650 | $698 | $809 | $769 | $1,641 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 75 | 75 | 52 |
| Retained earnings | -11,123 | -10,418 | -9,404 | -8,363 | -4,564 |
| Other shareholders' equity | 1,247 | 1,264 | 1,210 | 1,234 | 293 |
| TOTAL | $1,394 | $2,096 | $2,707 | $3,750 | $126 |
| Total Liabilities And Equity | $2,044 | $2,794 | $3,516 | $4,519 | $1,767 |